SCI Pharmtech Correlations
| 4119 Stock | TWD 97.50 0.50 0.51% |
The current 90-days correlation between SCI Pharmtech and CHC Healthcare Group is 0.13 (i.e., Average diversification). The correlation of SCI Pharmtech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
SCI Pharmtech Correlation With Market
Significant diversification
The correlation between SCI Pharmtech and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SCI Pharmtech and DJI in the same portfolio, assuming nothing else is changed.
SCI |
The ability to find closely correlated positions to SCI Pharmtech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SCI Pharmtech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SCI Pharmtech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SCI Pharmtech to buy it.
Moving against SCI Stock
| 0.83 | 3465 | New Advanced Electronics | PairCorr |
| 0.73 | 6785 | Alar Pharmaceuticals | PairCorr |
| 0.72 | 1516 | Falcon Power Split | PairCorr |
| 0.71 | 1438 | SanDi Properties | PairCorr |
| 0.63 | 1423 | Reward Wool Industry | PairCorr |
| 0.59 | 1713 | Cathay Chemical Works | PairCorr |
| 0.55 | 4174 | OBI Pharma | PairCorr |
| 0.49 | 1435 | Chung Fu Tex | PairCorr |
| 0.39 | 9902 | Tidehold Development | PairCorr |
| 0.33 | 0051 | YuantaP shares Taiwan | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between SCI Stock performing well and SCI Pharmtech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SCI Pharmtech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 4164 | 1.25 | (0.18) | 0.00 | (0.69) | 0.00 | 3.46 | 12.81 | |||
| 3164 | 0.69 | (0.21) | 0.00 | 6.31 | 0.00 | 1.32 | 4.87 | |||
| 1734 | 0.86 | (0.19) | 0.00 | 0.63 | 0.00 | 0.98 | 18.28 | |||
| 4133 | 0.41 | (0.12) | 0.00 | (0.38) | 0.00 | 0.68 | 4.50 | |||
| 4106 | 0.53 | (0.10) | 0.00 | (1.01) | 0.00 | 0.79 | 3.17 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in SCI Pharmtech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
SCI Pharmtech Corporate Management
Elected by the shareholders, the SCI Pharmtech's board of directors comprises two types of representatives: SCI Pharmtech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SCI. The board's role is to monitor SCI Pharmtech's management team and ensure that shareholders' interests are well served. SCI Pharmtech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SCI Pharmtech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| JunBang Ye | VP | Profile | |
| WenChih Chou | GM Pres | Profile | |
| Deiter Yang | CG Sec | Profile | |
| Michele Seah | VP | Profile | |
| Ricky Liu | Sustainable Mang | Profile |